Steven R. Visuri

Stem Pharm, Inc. is a neurological drug discovery platform company that uses a human-first approach to develop the next-generation of neurologic drugs. The company is based in Madison, WI, a hub for innovative stem cell and biosciences research. The company's proprietary drug discovery platform is based on human 3D neuro-immune organoids that feature microglia and model neuroinflammation, which play a critical role in many neurological diseases. Stem Pharm applies this platform to discover and validate disease targets and therapeutics for its internal programs in epilepsy, neurodegeneration, and brain cancer as well as for its biopharma partners' therapeutic programs. The company was founded in 2015 by William L. Murphy, Connie Lebakken, and the CEO is Steven R. Visuri.

Golden Angels Investors LLC (Golden Angels Investors) is a venture capital firm founded in 2002 by Timothy J Keane. The firm is headquartered in Brookfield, Wisconsin.

Prodesse, Inc. develops, manufactures, and distributes reagents for infectious disease agents. The company's products include Pro hMPV, for detection of human metapneumovirus; ProPneumo-1 that is for detection of mycoplasma pneumoniae and chlamydophila pneumoniae; ProPertussis, for detection of bordetella pertussis; ProGastro Cd for detection of toxigenic strains of clostridium difficile and Pro hMPV+, for detection of human metapneumovirus. It was founded in 1993 and is headquartered in Waukesha, WI

Floraseq LLC develops microbiota-based products. It provides therapeutic and diagnostic solutions to treat gastrointestinal disorders. The company was founded by Steve Visuri and Karen Harrington and in 2014 and is headquartered in Waukesha, WI.

Lawrence Livermore National Laboratory provides nuclear testing services. The Laboratory's security needs include countering the proliferation of weapons of mass destruction and strengthening homeland security against the terrorist use of such weapons. The company was founded in 1952 and is headquartered in Livermore, CA.